OraSure: Three Meaningful Catalysts Not Baked Into The Stock, Says Canaccord
In a research note released yesterday, Canaccord analyst Mark Massaro reiterated a Buy rating on OraSure Technologies (NASDAQ:OSUR) shares, and a $11 price target following investor meetings.
Massaro commented: “We are buyers of OraSure following strong investor meetings out of the Canaccord Genuity Growth Conference. We believe investor sentiment in OSUR is at the highest level in two years and continues to rise on the back of its HCV test. We believe there are three meaningful catalysts not priced into the stock today that will take the shares higher.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Mark Massaro has a total average return of -9.3% and a 20.0% success rate. Massaro has a 5.6% average return when recommending OSUR, and is ranked #2967 out of 3261 analysts.